“Doctor, Can I Drink Coffee with Atrial Fibrillation?” — A New Study Says THIS

Does coffee trigger atrial fibrillation—or could it actually protect against recurrence? A new randomized clinical trial published in JAMA (2025) studied patients with persistent atrial fibrillation or flutter who underwent cardioversion and followed them for 6 months. The surprising finding: Patients who continued drinking caffeinated coffee had a lower risk of AF/flutter recurrence compared to those who abstained. But the details matter. This study did NOT look at people who remained in persistent AF. It specifically looked at patients after successful cardioversion, and the protective effect was seen only in preventing recurrence, not in treating ongoing AF. In this video, I break down: What the DECAF randomized trial actually tested AF vs atrial flutter: quick explanation What “persistent AF undergoing cardioversion” means How hazard ratios are calculated Why the conclusion applies only to post-cardioversion recurrence—not all AF patients Should patients avoid or continue coffee? If you are a clinician, student, or patient with AFib, this evidence will help clarify a long-debated question: Is coffee safe—or even helpful—for AF? 💙 Want to support this work? ☕ Buy me a coffee: https://www.buymeacoffee.com/DrMobeenSyed 🎥 Become a patron: https://www.patreon.com/mobeensyed?fan_landing=true 💵 PayPal: https://paypal.me/mobeensyed?locale.x=en_US 📬 My Substack: https://mobeensyedmd.substack.com/ 🛑 Medical Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health-related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. 📌 Reference: JAMA 2025 – Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation (DECAF Trial)